Skip to content
healthcare.dev

PURIXAN

NDC 62484-0020, Purixan, suspension, from Nova Laboratories, Ltd.

Product NDC
62484-0020
Status
Listed
Labeler
Nova Laboratories, Ltd
Dosage form
SUSPENSION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA205919
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/62484-0020 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • MERCAPTOPURINE20 mg/mL

Pharmacologic classes

Nucleic Acid Synthesis Inhibitors [MoA]; Nucleoside Metabolic Inhibitor [EPC]

Package NDCNDC-11Package
62484-0020-2624840020021 BOTTLE in 1 CARTON (62484-0020-2) / 100 mL in 1 BOTTLE (62484-0020-1)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/9fd27952-7787-47d9-b6cf-7af2dc38217b

Use it

Look up 62484-0020 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/62484-0020 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 62484-0020. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.